BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31949778)

  • 1. Genome-wide SNP and InDel mutations in Mycobacterium tuberculosis associated with rifampicin and isoniazid resistance.
    Li H; Guo H; Chen T; Yu L; Chen Y; Zhao J; Yan H; Chen M; Sun Q; Zhang C; Zhou L; Chen L
    Int J Clin Exp Pathol; 2018; 11(8):3903-3914. PubMed ID: 31949778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole genome analysis of an MDR Beijing/W strain of Mycobacterium tuberculosis with large genomic deletions associated with resistance to isoniazid.
    Zhang Q; Wan B; Zhou A; Ni J; Xu Z; Li S; Tao J; Yao Y
    Gene; 2016 May; 582(2):128-36. PubMed ID: 26854371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan.
    Kozhamkulov U; Akhmetova A; Rakhimova S; Belova E; Alenova A; Bismilda V; Chingissova L; Ismailov S; Ramanculov E; Momynaliev K
    Jpn J Infect Dis; 2011; 64(3):253-5. PubMed ID: 21617314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal whole genome analysis of pre and post drug treatment Mycobacterium tuberculosis isolates reveals progressive steps to drug resistance.
    Datta G; Nieto LM; Davidson RM; Mehaffy C; Pederson C; Dobos KM; Strong M
    Tuberculosis (Edinb); 2016 May; 98():50-5. PubMed ID: 27156618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.
    Valvatne H; Syre H; Kross M; Stavrum R; Ti T; Phyu S; Grewal HM
    J Antimicrob Chemother; 2009 Oct; 64(4):694-701. PubMed ID: 19710078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide DNA methylation and transcriptome changes in Mycobacterium tuberculosis with rifampicin and isoniazid resistance.
    Chen L; Li H; Chen T; Yu L; Guo H; Chen Y; Chen M; Li Z; Wu Z; Wang X; Zhao J; Yan H; Wang X; Zhou L; Zhou J
    Int J Clin Exp Pathol; 2018; 11(6):3036-3045. PubMed ID: 31938429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation.
    Afanas'ev MV; Ikryannikova LN; Il'ina EN; Sidorenko SV; Kuz'min AV; Larionova EE; Smirnova TG; Chernousova LN; Kamaev EY; Skorniakov SN; Kinsht VN; Cherednichenko AG; Govorun VM
    J Antimicrob Chemother; 2007 Jun; 59(6):1057-64. PubMed ID: 17442757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review.
    Seifert M; Catanzaro D; Catanzaro A; Rodwell TC
    PLoS One; 2015; 10(3):e0119628. PubMed ID: 25799046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid detection of specific gene mutations associated with isoniazid or rifampicin resistance in Mycobacterium tuberculosis clinical isolates using non-fluorescent low-density DNA microarrays.
    Aragón LM; Navarro F; Heiser V; Garrigó M; Español M; Coll P
    J Antimicrob Chemother; 2006 May; 57(5):825-31. PubMed ID: 16547071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Description of Mycobacterium tuberculosis mutations conferring resistance to rifampicin and isoniazid detected by GenoType® MTBDRplus V.2 in Colombia].
    Llerena C; Medina R
    Biomedica; 2017 Jan; 37(1):28-33. PubMed ID: 28527245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of mutations associated with isoniazid resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Jagielski T; Bakuła Z; Roeske K; Kamiński M; Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J
    J Antimicrob Chemother; 2014 Sep; 69(9):2369-75. PubMed ID: 24855126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of mutations causing rifampicin and isoniazid resistance of Mycobacterium tuberculosis in Syria.
    Madania A; Habous M; Zarzour H; Ghoury I; Hebbo B
    Pol J Microbiol; 2012; 61(1):23-32. PubMed ID: 22708343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insight into the molecular characterization of isoniazid and rifampicin resistant Mycobacterium tuberculosis strains from Saudi Arabia.
    Varghese B; Hillemann A; Wijayanti DR; Shoukri M; Al-rabiah F; Al-Omari R; Al-Hajoj S
    Infect Genet Evol; 2012 Apr; 12(3):549-56. PubMed ID: 22326932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The occurrence and frequency of genomic mutations that mediate Isoniazid and Rifampicin resistance in
    Kumwenda GP; Chipungu G; Sloan DJ; Kaimila Y; Chiumya K; Pangani H
    Malawi Med J; 2018 Mar; 30(1):1-5. PubMed ID: 29868151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of reasons of the MDR M. tuberculosis strains dissemination by analysis of the rifampicin and/or isoniazid resistant isolates].
    Sivkov AIu; Boldyrev AN; Azaev MSh; Bodnev SA; Medvedeva EV; Baranova OI; Ivlev-Dantau AP; Blinova LN; Pasechnikov AD; Tat'kov SI
    Mol Gen Mikrobiol Virusol; 2006; (2):20-5. PubMed ID: 16755998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-genome sequencing and single nucleotide polymorphisms in multidrug-resistant clinical isolates of Mycobacterium tuberculosis from the Philippines.
    Roa MB; Tablizo FA; Morado EKD; Cunanan LF; Uy IDC; Ng KCS; Manalastas-Cantos KG; Reyes JM; Ganchua SKC; Ang CF; Kato-Maeda M; Cattamanchi A; Karaoz U; Destura RV; Lluisma AO
    J Glob Antimicrob Resist; 2018 Dec; 15():239-245. PubMed ID: 30130640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Line probe assay for detection of rifampicin and isoniazid resistant tuberculosis in Pakistan.
    Farooqi JQ; Khan E; Alam SM; Ali A; Hasan Z; Hasan R
    J Pak Med Assoc; 2012 Aug; 62(8):767-72. PubMed ID: 23862246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole genome sequencing based characterization of extensively drug-resistant Mycobacterium tuberculosis isolates from Pakistan.
    Ali A; Hasan Z; McNerney R; Mallard K; Hill-Cawthorne G; Coll F; Nair M; Pain A; Clark TG; Hasan R
    PLoS One; 2015; 10(2):e0117771. PubMed ID: 25719196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Spectrum of Mutations in Genes Associated with Resistance to Rifampicin, Isoniazid, and Fluoroquinolones in the Clinical Strains of M. tuberculosis Reflects the Transmissibility of Mutant Clones].
    Ergeshov A; Andreevskaya SN; Larionova EE; Smirnova TG; Chernousova LN
    Mol Biol (Mosk); 2017; 51(4):595-602. PubMed ID: 28900077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.